Hoth Therapeutics HOTH 深 沪
等待开盘 06-26 09:30:00 美东时间
1.36
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 1.36
- 总市值 4.38万
- 52周最高 2.115
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.49
- 委 比 0.00%
- 总股本 3.22万
- 历史最高 13.88
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.236
- 每 手 1
- 风险率 0.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Space Stocks Get Torched: Short Seller Calls Them 'Sci-Fi Wishes'
Space stocks get hit hard as SpaceX opens for trading and a short seller targets six companies in the sector.
06-13 03:33
EXCLUSIVE: Hoth Therapeutics To Rebrand To Pursue AI Chip Technologies
Hoth Therapeutics plans Rocket One rebrand to pursue AI semiconductor and spintronic computing opportunities.
05-19 19:46
Hoth Therapeutics Announces $2M Direct Offering At $0.70/Shr
Hoth Therapeutics, Inc. (NASDAQ:HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapies for unmet medical needs, today announced that it has entered into a definitive agreement for
04-02 01:56
Hoth Therapeutics Reports Data For HT-001; No Serious Adverse Events
PK studies of topical HT-001 reveal limited systemic absorption and ~99% reduced systemic levels as compared to FDA approved oral formulations.
03-24 20:15
Hoth Therapeutics Expands Oncology Pipeline With Dual Patent Filings
The first provisional patent application, titled covering the topical treatment of radiation-induced skin toxicity in oncology patients.The second provisional patent application, titled addressing dermatologic toxicities
01-02 21:20
Hoth Therapeutics Reports Pipeline Progress Across HT‑001, HT‑KIT, HT‑ALZ And New GDNF Program, Expands IP Portfolio And Partnerships
Hoth Therapeutics, Inc. (NASDAQ:HOTH), a patient-focused clinical-stage biopharmaceutical company, today issued a comprehensive update on its therapeutic pipeline. The Company detailed meaningful progress across HT-001,
2025-12-04 03:04
Hoth Therapeutics Joins NVIDIA Connect Program To Accelerate AI-Driven Drug Development
Hoth Therapeutics, Inc. (NASDAQ:HOTH), a clinical-stage biopharmaceutical company focused on developing breakthrough therapeutics today announced that it has been officially accepted into the NVIDIA Connect Program, a
2025-11-20 21:14
Artelo Biosciences盘中异动 下午盘快速下挫5.36%
北京时间2025年01月09日03时54分，Artelo Biosciences, Inc.（ARTL.us）股票出现波动，股价急速下跌5.36%。截至发稿，该股报1.09美元/股，成交量1.6728万股，换手率0.52%，振幅4.50%。 最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.13百万美元，每股收益-0.35美元，毛利0.00美元，市盈率-0.39倍。 机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。 Artelo Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Sana ...
2025-01-09 03:54
Why Argan Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Shares of Argan, Inc. (NYSE:AGX) rose sharply in today's pre-market trading aft...
2024-09-06 17:41
EF Hutton Maintains Buy on Hoth Therapeutics, Maintains $5 Price Target
EF Hutton analyst Jason Kolbert maintains Hoth Therapeutics (NASDAQ:HOTH) with a Buy and maintains $5 price target.
2024-09-06 03:06
